abc biopply is an innovative, dynamic biotech company headquartered in Solothurn and with laboratory and research facilities in Cham, Switzerland.
The company was founded in 2015 with the aim to substantially improve and support the transition from scientific research to clinical applications.
abc biopply devotes its know-how and expertise in complex cell culture technologies to define and standardise workflows, technologies and protocols in translational medicine.
With 3D CoSeedis™ abc biopply presents a novel and innovative 3D cell culture system that fulfils our criteria in standardisation. Its unique features are: